Transcranial magnetic stimulation (TMS)/repetitive TMS in mild cognitive impairment and Alzheimer's disease

Acta Neurologica Scandinavica

Volumn 129, Issue 6, 2014, Pages 351-366

  Nardone, R ^a,b,d   Tezzon, F ^b   Holler Y ^a   Golaszewski, S ^a   Trinka, E ^a   Brigo, F ^b,c  

^a PARACELSUS MEDICAL UNIVERSITY   (Austria)

^b FRANZ TAPPEINER HOSPITAL   (Italy)

^c UNIVERSITY OF VERONA   (Italy)

^d Department of Neurology F Tappeiner Hospital Meran/o ^*  (Italy)

Author keywords

Afferent inhibition; Alzheimer's disease; Cortical plasticity; Intracortical inhibition; Mild cognitive impairment; Transcranial magnetic stimulation

Indexed keywords

ALZHEIMER DISEASE; ARTICLE; ELECTROENCEPHALOGRAPHY; EXCITABILITY; HUMAN; MILD COGNITIVE IMPAIRMENT; NERVE CELL NETWORK; NERVE CELL PLASTICITY; TRANSCRANIAL MAGNETIC STIMULATION; ANIMAL; BRAIN; PATHOPHYSIOLOGY; PROCEDURES;

ALZHEIMER DISEASE; ANIMALS; BRAIN; HUMANS; MILD COGNITIVE IMPAIRMENT; NEURONAL PLASTICITY; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 84897963173     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/ane.12223     Document Type: Article

References (125)

1. Guse B, Falkai P, Wobrock T. Cognitive effects of high-frequency repetitive transcranial magnetic stimulation: a systematic review. J Neural Transm 2010;117:105-22.
2. Rossi S, Cappa S F, Babiloni C et al. Prefrontal [correction of Prefontal] cortex in long-term memory: an 'interference' approach using magnetic stimulation. Nat Neurosci 2001;4:948-52.
3. Sandrini M, Cappa SF, Rossi S, Rossini PM, Miniussi C. The role of prefrontal cortex in verbal episodic memory: rTMS evidence. J Cogn Neurosci 2003;15:855-61.
4. Manenti R, Cotelli M, Calabria M, Maioli C, Miniussi C. The role of the dorsolateral prefrontal cortex in retrieval from long-term memory depends on strategies: a repetitive transcranial magnetic stimulation study. Neuroscience 2010;166:501-7.
5. Manenti R, Tettamanti M, Cotelli M, Miniussi C, Cappa SF. The neural bases of word encoding and retrieval: a fMRI-guided transcranial magnetic stimulation study. Brain Topogr 2010;22:318-32.
6. Cotelli M, Manenti R, Zanetti O, Miniussi C. Non-pharmacological intervention for memory decline. Front Hum Neurosci 2012;6:46.
7. Manenti R, Brambilla M, Petesi M, Ferrari C, Cotelli M. Enhancing verbal episodic memory in older and young subjects after non-invasive brain stimulation. Front Aging Neurosci 2013;5:49.
8. Sparing R, Mottaghy FM. Noninvasive brain stimulation with transcranial magnetic or direct current stimulation (TMS/tDCS)-From insights into human memory to therapy of its dysfunction. Methods 2008;44:329-37.
9. Freitas C, Mondragón-Llorca H, Pascual-Leone A. Noninvasive brain stimulation in Alzheimer's disease: Systematic review and perspectives for the future. Exp Gerontol 2011;46:611-27.
10. Boggio PS, Valesek CA, Campanhã C et al. Non-invasive brain stimulation to assess and modulate neuroplasticity in Alzheimer's disease. Neuropsychol Rehabil 2011;21:703-16.
11. Ziemann U, Lonnecker S, Steinhoff BJ, Paulus W. The effect of lorazepam on the motor cortex excitability in man. Exp Brain Res 1996;109:127-35.
12. Ziemann U, Lonnecker S, Steinhoff BH, Paulus W. Effects of antiepileptics drugs on motor cortex excitability in humans: a transcranial magnetic stimulation study. Ann Neurol 1996;40:367-78.
13. Di Lazzaro V, Oliviero A, Pilato F, Saturno E, Dileone M, Tonali PA. Motor cortex hyperexcitability to transcranial magnetic stimulation in Alzheimer's disease; evidence of impaired glutamatergic neurotransmission? Ann Neurol 2003;53:824.
14. Di Lazzaro V, Oliviero A, Profice P et al. Ketamine increases human motor cortex excitability to transcranial magnetic stimulation. J Physiol 2003;547:485-96.
15. Hallett M. Transcranial magnetic stimulation and the human brain. Nature 2000;406:147-50.
16. Kobayashi M, Pascual-Leone A. Transcranial magnetic stimulation in neurology. Lancet Neurol 2003;2:145-56.
17. Groppa S, Oliviero A, Eisen A et al. A practical guide to diagnostic transcranial magnetic stimulation: a report of an IFCN committee. Clin Neurophysiol 2012;123:858-82.
18. Delvendahl I, Jung NH, Kuhnke NG, Ziemann U, Mall V. Plasticity of motor threshold and motor-evoked potential amplitude - a model of intrinsic synaptic plasticity in human motor cortex? Brain Stimul 2012;5:586-93.
19. Rothwell JC, Hallett M, Berardelli A, Eisen A, Rossini P, Paulus W. Magnetic stimulation: motor evoked potentials. The international federation of clinical neurophysiology. Electroencephalogr Clin Neurophysiol Suppl 1999;52:97-103.
20. Ferbert A, Priori A, Rothwell JC, Day BL, Colebatch JG, Marsden CD. Interhemispheric inhibition of the human motor cortex. J Physiol 1992;453:525-46.
21. Rossini PM, Barker AT, Berardelli A et al. Non invasive electrical and magnetic stimulation of the brain, spinal cord and roots: basic principles and procedures for routine clinical application: report of IFCN committee. Electroencephalogr Clin Neurophysiol 1994;91:79-92.
22. Kujirai T, Caramia MD, Rothwell JC et al. Corticocortical inhibition in human motor cortex. J Physiol 1993;471:501-19.
23. Paulus W, Classen J, Cohen LG et al. State of the art: pharmacologic effects on cortical excitability measures tested by transcranial magnetic stimulation. Brain Stimul 2008;1:151-63.
24. Ziemann U, Paulus W, Nitsche MA et al. Consensus: motor cortex plasticity protocols. Brain Stimul 2008;1:164-82.
25. Tokimura H, Di Lazzaro V, Tokimura Y et al. Short latency inhibition of human hand motor cortex by somatosensory input from the hand. J Physiol 2000;523:503-13.
26. Di Lazzaro V, Oliviero A, Profice P et al. Muscarinic receptor blockade has differential effects on the excitability of intracortical circuits in the human motor cortex. Exp Brain Res 2000;135:455-61.
27. Di Lazzaro V, Oliviero A, Pilato F et al. Neurophysiological predictors of long term response to AChE inhibitors in AD patients. J Neurol Neurosurg Psychiatry 2005;76:1064-9.
28. Fujiki M, Hikawa T, Abe T, Ishii K, Kobayashi H. Reduced short latency afferent inhibition in diffuse axonal injury patients with memory impairment. Neurosci Lett 2006;405:226-30.
29. Sailer A, Molnar GF, Paradiso G, Gunraj CA, Lang AE, Chen R. Short and long latency afferent inhibition in Parkinson's disease. Brain 2003;26:1883-94.
30. Thut G, Ives JR, Kampmann F, Pastor MA, Pascual-Leone A. A new device and protocol for combining TMS and online recordings of EEG and evoked potentials. J Neurosci Methods 2005;141:207-17.
31. Ives JR, Rotenberg A, Poma R, Thut G, Pascual-Leone A. Electroencephalographic recording during transcranial magnetic stimulation in humans and animals. Clin Neurophysiol 2006;117:1870-5.
32. Thut G, Pascual-Leone A. A review of combined TMS-EEG studies to characterize lasting effects of repetitive TMS and assess their usefulness in cognitive and clinical neuroscience. Brain Topogr 2010;22:219-32.
33. Babiloni C, Infarinato F, Aujard F. Effects of pharmacological agents, sleep deprivation, hypoxia and transcranial magnetic stimulation on electroencephalographic rhythms in rodents: toward translational challenge models for drug discovery in Alzheimer's disease. Clin Neurophysiol 2013;124:437-51.
34. Chen R, Udupa K. Measurement and modulation of plasticity of the motor system in humans using transcranial magnetic stimulation. Mot Control 2009;13:442-53.
35. Stefan K, Kunesch E, Benecke R, Cohen LG, Classen J. Mechanisms of enhancement of human motor cortex excitability induced by interventional paired associative stimulation. J Physiol 2002;543:699-708.
36. Quartarone A, Rizzo V, Bagnato S et al. Rapid-rate paired associative stimulation of the median nerve and motor cortex can produce long-lasting changes in motor cortical excitability in humans. J Physiol 2006;575:657-70.
37. Pascual-Leone A, Valls-Solé J, Brasil-Neto JP. Akinesia in Parkinson's disease. II. Effects of subthreshold repetitive transcranial motor cortex stimulation. Neurology 1994;44:892-8.
38. Lee L, Siebner HR, Rowe JB et al. Acute remapping within the motor system induced by low-frequency repetitive transcranial magnetic stimulation. J Neurosci 2003;2003(23):5308-18.
39. Berardelli A, Inghilleri M, Rothwell JC et al. Facilitation of muscle evoked responses after repetitive cortical stimulation in man. Exp Brain Res 1998;122:79-84.
40. Pascual-Leone A, Tormos JM, Keenan J, Tarazona F, Canete C, Catala MD. Study and modulation of human cortical excitability with transcranial magnetic stimulation. J Clin Neurophysiol 1998;15:333-43.
41. Di Lazzaro V, Pilato F, Saturno E et al. Theta-burst repetitive transcranial magnetic stimulation suppresses specific excitatory circuits in the human motor cortex. J Physiol 2005;565:945-50.
42. Huang YZ, Edwards MJ, Rounis E, Bhatia KP, Rothwell JC. Theta burst stimulation of the human motor cortex. Neuron 2005;45:201-6.
43. de Carvalho M, de Mendonça A, Miranda PC, Garcia C, Luis MC. Magnetic stimulation in Alzheimer's disease. J Neurol 1997;244:304-47.
44. Pepin JL, Bogacz D, de Pasqua V, Delwaide PJ. Motor cortex inhibition is not impaired in patients with Alzheimer's disease: evidence from paired transcranial magnetic stimulation. J Neurol Sci 1999;170:119-23.
45. Alagona G, Bella R, Ferri R et al. Transcranial magnetic stimulation in Alzheimer disease: motor cortex excitability and cognitive severity. Neurosci Lett 2001;314:57-60.
46. Alagona G, Ferri R, Pennisi G et al. Motor cortex excitability in Alzheimer's disease and in subcortical ischemic vascular dementia. Neurosci Lett 2004;362:95-8.
47. Di Lazzaro V, Oliviero A, Tonali PA et al. Noninvasive in vivo assessment of cholinergic cortical circuits in AD using transcranial magnetic stimulation. Neurology 2002;59:392-7.
48. Di Lazzaro V, Oliviero A, Pilato F et al. Motor cortex hyperexcitability to transcranial magnetic stimulation in Alzheimer's disease. J Neurol Neurosurg Psychiatry 2004;75:555-9.
49. Di Lazzaro V, Pilato F, Dileone M et al. Functional evaluation of cerebral cortex in dementia with Lewy bodies. Neuroimage 2007;37:422-9.
50. Di Lazzaro V, Pilato F, Dileone M et al. In vivo functional evaluation of central cholinergic circuits in vascular dementia. Clin Neurophysiol 2008;119:2494-500.
51. Martorana A, Stefani A, Calmieri MG et al. L-dopa modulates motor cortex excitability in Alzheimer's disease patients. J Neural Transm 2008;115:1313-9.
52. Martorana A, Mori F, Esposito Z. Dopamine modulates cholinergic cortical excitability in Alzheimer's disease patients. Neuropsychopharmacology 2009;34:2323-8.
53. Inghilleri M, Conte A, Frasca V et al. Altered response to rTMS in patients with Alzheimer's disease. Clin Neurophysiol 2006;117:103-9.
54. Julkunen P, Jauhiainen AM, Westerén-Punnonen S et al. Navigated TMS combined with EEG in mild cognitive impairment and Alzheimer's disease: a pilot study. J Neurosci Methods 2008;172:270-6.
55. Hoeppner J, Wegrzyn M, Thome J et al. Intra- and inter-cortical motor excitability in Alzheimer's disease. J Neural Transm 2012;119:605-12.
56. Liepert J, Bär KJ, Meskea U, Weiller C. Motor cortex disinhibition in Alzheimer's disease. Clin Neurophysiol 2001;112:1436-41.
57. Pennisi G, Alagona G, Ferri R et al. Motor cortex excitability in Alzheimer disease: one year follow-up study. Neurosci Lett 2002;329:293-6.
58. Ferreri F, Pauri F, Pasqualetti P, Fini G, Dal Forno G, Rossini PM. Motor cortex excitability in Alzheimer's disease: a transcranial magnetic stimulation study. Ann Neurol 2003;53:102-8.
59. Nardone R, Bratti A, Tezzon F. Motor cortex inhibitory circuits in dementia with Lewy bodies and in Alzheimer's disease. J Neural Transm 2006;113:1679-84.
60. Nardone R, Bergmann J, Kronbichler M et al. Abnormal short latency afferent inhibition in early Alzheimer's disease: a transcranial magnetic demonstration. J Neural Transm 2008;115:1557-62.
61. Sakuma K, Murakami T, Nakashima K. Short latency afferent inhibition is not impaired in mild cognitive impairment. Clin Neurophysiol 2007;118:1460-3.
62. Battaglia F, Wang HY, Ghilardi MF et al. Cortical plasticity in Alzheimer's disease in humans and rodents. Biol Psychiatry 2007;62:1405-12.
63. Alberici A, Bonato C, Calabria M et al. The contribution of TMS to frontotemporal dementia variants. Acta Neurol Scand 2008;118:275-80.
64. Olazarán J, Prieto J, Cruz I, Esteban A. Cortical excitability in very mild Alzheimer's disease: a long-term follow-up study. J Neurol 2010;257:2078-85.
65. Pierantozzi M, Panella M, Palmieri MG et al. Different TMS patterns of intracortical inhibition in early onset Alzheimer dementia and frontotemporal dementia. Clin Neurophysiol 2004;15:2410-8.
66. Perretti A, Grossi D, Fragassi N et al. Evaluation of the motor cortex by magnetic stimulation in patients with Alzheimer disease. J Neurol Sci 1996;135:31-7.
67. Niskanen E, Könönen M, Määttä S et al. New insights into Alzheimer's disease progression: a combined TMS and structural MRI study. PLoS ONE 2011;6:e26113.
68. Lowe SL, Bowen DM, Francis PT, Neary D. Ante mortem cerebral amino acid concentrations indicate selective degeneration of glutamate-enriched neurons in Alzheimer's disease. Neuroscience 1990;38:571-7.
69. Lowe SL, Francis PT, Procter AW, Palmer AM, Davison AN, Bowen DM. Gamma-aminobutyric acid concentrations in brain tissue at two stages of Alzheimer's disease. Brain 1988;111:785-99.
70. Farlow MR. NMDA receptor antagonists: a new therapeutic approach for Alzheimer's disease. Geriatrics 2004;59:22-7.
71. Hynd MR, Scott HL, Dodd PR. Glutamate-mediated excitotoxicity and neurodegeneration in Alzheimer's disease. Neurochem Int 2004;45:583-95.
72. Tsutsumi R, Hanajima R, Hamada M et al. Reduced interhemispheric inhibition in mild cognitive impairment. Exp Brain Res 2012;218:21-6.
73. Di Lazzaro V, Pilato F, Dileone M et al. In vivo cholinergic circuit evaluation in frontotemporal and Alzheimer dementias. Neurology 2006;66:1111-3.
74. Davies P, Maloney AJ. Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet 1976;2:1403.
75. Whitehouse PJ, Price DL, Struble RG, Clark AW, Coyle JT, Delon MR. Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. Science 1982;215:1237-9.
76. Coyle JT, Price DL, Delong MR. Alzheimer's disease: a disorder of cortical cholinergic innervation. Science 1983;219:1184-90.
77. Marra C, Quaranta D, Profice P et al. Central cholinergic dysfunction measured 'in vivo' correlates with different behavioral disorders in Alzheimer's disease and dementia with Lewy body. Brain Stimul. 2012;5:533-8.
78. Petersen RC, Doody R, Kurz A et al. Current concepts in mild cognitive impairment. Arch Neurol 2001;58:1985-92.
79. Nardone R, Bergmann J, Christova M et al. Short latency afferent inhibition differs among the subtypes of mild cognitive impairment. J Neural Transm 2012;119:463-71.
80. Di Lorenzo F, Martorana A, Ponzo V et al. Cerebellar theta burst stimulation modulates short latency afferent inhibition in Alzheimer's disease patients. Front Aging Neurosci 2013;5:2.
81. Ferreri F, Pasqualetti P, Määttä S et al. Motor cortex excitability in Alzheimer's disease: a transcranial magnetic stimulation follow-up study. Neurosci Lett 2011;492:94-8.
82. Carpenter P, Lavenu I, Pasquier F, Sterling M. Alzheimer's disease and frontotemporal dementia are differentiated by discriminant analysis applied to (99 m)Tc HmPAO SPECT data. J Neurol Neurosurg Psychiatry 2000;69:661-3.
83. Nobili F, Koulibaly M, Vitali P et al. Brain perfusion follow-up in Alzheimer's patients during treatment with acetylcholinesterase inhibitors. J Nucl Med 2002;43:983-90.
84. Trebbastoni A, Gilio F, D'antonio F et al. Chronic treatment with rivastigmine in patients with Alzheimer's disease: a study on primary motor cortex excitability tested by 5 Hz-repetitive transcranial magnetic stimulation. Clin Neurophysiol 2012;123:902-9.
85. Koch G, Esposito Z, Codecà C et al. Altered dopamine modulation of LTD-like plasticity in Alzheimer's disease patients. Clin Neurophysiol 2011;122:703-7.
86. Koch G, Di Lorenzo F, Bonnì S, Ponzo V, Caltagirone C, Martorana A. Impaired LTP- but not LTD in Alzheimer's disease patients. J Alzheimers Dis 2012;31:593-9.
87. Terranova C, Santangelo A, Morgante F et al. Impairment of sensory-motor plasticity in mild Alzheimer's disease. Brain Stimul 2013;6:62-6.
88. Julkunen P, Jauhiainen AM, Könönen M, Pääkkönen A, Karhu J, Soininen H. Combining transcranial magnetic stimulation and electroencephalography may contribute to assess the severity of Alzheimer's disease. Int J Alzheimers Dis 2011;2011:654794.
89. Bonnì S, Lupo F, Lo Gerfo E et al. Altered parietal-motor connections in Alzheimer's disease patients. J Alzheimers Dis 2013;33:525-33.
90. Bracco L, Giovannelli F, Bessi V et al. Mild cognitive impairment: loss of linguistic task-induced changes in motor cortex excitability. Neurology 2009;72:928-34.
91. Nitsche MA, Paulus W. Excitability changes induced in the human motor cortex by weak transcranial direct current stimulation. J Physiol 2000;527:633-9.
92. Fitzgerald PB, Fountain S, Daskalakis ZJ. A comprehensive review of the effects of rTMS on motor excitability and inhibition. Clin Neurophysiol 2006;117:2584-96.
93. Wagner T, Valero-Cabre A, Pascual-Leone A. Noninvasive human brain stimulation. Annu Rev Biomed Eng 2007;9:527-65.
94. Hoogendam M, Ramakers GM, Di Lazzaro V. Physiology of repetitive transcranial magnetic stimulation of the human brain. Brain Stimul 2010;3:95-118.
95. Wang L, Zang Y, He Y et al. Changes in hippocampal connectivity in the early stages of Alzheimer's disease: evidence from resting state fMRI. Neuroimage 2006;31:496-504.
96. Bai F, Zhang Z, Watson DR et al. Abnormal functional connectivity of hippocampus during episodic memory retrieval processing network in amnestic type mild cognitive impairment. Biol Psychiatry 2009;65:951-8.
97. Sperling RA, Dickerson BC, Pihlajamaki M et al. Functional alterations in memory networks in early Alzheimer's disease. Neuromolecular Med 2010;12:27-43.
98. Grady CL, Mcintosh AR, Beig S, Craik FI. An examination of the effects of stimulus type, encoding task, and functional connectivity on the role of right prefrontal cortex in recognition memory. Neuroimage 2001;14:556-71.
99. Smith GE, Pankratz VS, Negasi S et al. A plateau in pre-Alzheimer memory decline: evidence for compensatory mechanisms? Neurology 2007;69:133-9.
100. Turriziani P, Smirni D, Zappalà G, Mangano GR, Oliveri M, Cipolotti L. Enhancing memory performance with rTMS in healthy subjects and individuals with Mild Cognitive Impairment: the role of the right dorsolateral prefrontal cortex. Front Hum Neurosci 2012;6:62.
101. Fregni F, Pascual-Leone A. Technology insight: non-invasive brain stimulation in neurology-perspectives on the therapeutic potential of rTMS and tDCS. Nat Clin Pract Neurol 2007;3:383-93.
102. Cotelli M, Manenti R, Cappa SF, Geroldi C, Zanetti O, Rossini PM. Effect of transcranial magnetic stimulation on action naming in patients with Alzheimer disease. Arch Neurol 2006;63:1602-4.
103. Cotelli M, Manenti R, Cappa SF, Zanetti O, Miniussi C. Transcranial magnetic stimulation improves naming in Alzheimer disease patients at different stages of cognitive decline. Eur J Neurol 2008;15:1286-92.
104. Cotelli M, Calabria M, Manenti R et al. Improved language performance in Alzheimer disease following brain stimulation. J Neurol Neurosurg Psychiatry 2011;82:794-7.
105. Cotelli M, Calabria M, Manenti R et al. Brain stimulation improves associative memory in an individual with amnestic mild cognitive impairment. Neurocase 2012;18:17-23.
106. Ahmed MA, Darwish ES, Khedr EM, El Serogy YM, Ali AM. Effects of low versus high frequencies of repetitive transcranial magnetic stimulation and functional excitability in Alzheimer's dementia. J Neurol 2011;259:83-92.
107. Bentwich J, Dobronevsky E, Aichenbaum S et al. Beneficial effect of repetitive transcranial magnetic stimulation combined with cognitive training for the treatment of Alzheimer's disease: a proof of concept study. J Neural Transm 2009;118:463-71.
108. Rabey JM, Dobronevsky E, Aichenbaum S, Gonen O, Marton RG, Khaigrekht M. Repetitive transcranial magnetic stimulation combined with cognitive training is a safe and effective modality for the treatment of Alzheimer's disease: a randomized, double-blind study. J Neural Transm 2013;120:813-9.
109. Haffen E, Chopard G, Pretalli JB et al. A case report of daily prefrontal repetitive transcranial magnetic stimulation (rTMS) as an adjunctive treatment for Alzheimer disease. Brain Stimul 2012;5:264-6.
110. Rossi S, Rossini PM. TMS in cognitive plasticity and the potential for rehabilitation. Trends Cogn Sci 2004;8:273-9.
111. Rinne JO, Kaasinen V, Järvenpää T et al. Brain acetylcholinesterase activity in mild cognitive impairment and early Alzheimer's disease. J Neurol Neurosurg Psychiatry 2003;74:113-5.
112. Herholz K, Weisenbach S, Zundorf G, Lenz O, Schröder H, Bauer B. In-vivo study of acetylcholineesterase in basal forebrain, amygdala, and cortex in mild to moderate Alzheimer disease. Neuroimage 2004;21:136-43.
113. Stokin GB, Lillo C, Falzone TL et al. Axonopathy and transport deficits early in the pathogenesis of Alzheimer's disease. Science 2005;307:1282-8.
114. Dickerson B, Dickerson C, Bakkour A et al. The cortical signature of Alzheimer's disease: regionally specific cortical thinning relates to symptom severity in very mild to mild AD dementia and is detectable in asymptomatic amyloid-positive individuals. Cereb Cortex 2009;19:497-510.
115. Bakkur A, Morris JC, Dickerson BC. The cortical signature of prodromal AD: regional thinning predicts mild AD dementia. Neurology 2009;72:1048-55.
116. Wagner T, Gangitano M, Romero R et al. Intracranial measurement of current densities induced by transcranial magnetic stimulation in the human brain. Neurosci Lett 2004;354:91-4.
117. Wagner T, Eden U, Fregni F et al. Transcranial magnetic stimulation and brain atrophy: a computer-based human brain model study. Exp Brain Res 2008;186:539-50.
118. List J, Kübke JC, Lindenberg R et al. Relationship between excitability, plasticity and thickness of the motor cortex in older adults. Neuroimage, 2013;83:809-16.
119. Cheeran B, Talelli P, Mori F et al. A common polymorphism in the brain-derived neurotrophic factor gene (BDNF) modulates human cortical plasticity and the response to rTMS. J Physiol 2008;586:5717-25.
120. Wolk DA, Dickerson BC. Apolipoprotein E (APOE) genotype has dissociable effects on memory and attentional-executive network function in Alzheimer's disease. Proc Natl Acad Sci USA 2010;107:10256-61.
121. Koch G, Esposito Z, Kusayanagi H et al. CSF tau levels influence cortical plasticity in Alzheimer's disease patients. J Alzheimers Dis 2011;26:181-6.
122. Herwig U, Padberg F, Unger J, Spitzer M, Schönfeldt-Lecuona C. Transcranial magnetic stimulation in therapy studies: examination of the reliability of 'standard' coil positioning by neuronavigations. Biol Psychiatry 2001;50:58-61.
123. Solé-Padullés C, Bartrés-Faz D, Junqué C et al. Repetitive transcranial magnetic stimulation effects on brain function and cognition among elders with memory dysfunction. A randomized sham-controlled study. Cereb Cortex 2006;16:1487-93.
124. Silvanto J, Pascual-Leone A. State-dependency of transcranial magnetic stimulation. Brain Topogr 2008;21(1):1-10.
125. Rossi S, Hallett M, Rossini PM, Pascual-Leone A, Safety of TMS Consensus Group. Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research. Clin Neurophysiol 2009;120:2008-39.